Capsule Endoscopy Market Size & Growth Forecast 2026–2035, By Segments (End-use, Type, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Capsule Endoscopy Market size was worth USD 629.13 Million in 2025 and is expected to grow at a 9.5% CAGR between 2026 and 2035, crossing USD 1.56 Billion by 2035. The industry revenue for 2026 is calculated at USD 681.23 million.

• Base Year Value (2025): USD 629.13 Million
• CAGR (2026-2035): 9.5%
• Forecast Year Value (2035): USD 1.56 Billion
• Historical Data Period: 2022-2025
• Largest Region: North America
• Forecast Period: 2026-2035

Capsule Endoscopy Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America held 46.16% share in 2025 due to established gastrointestinal diagnostic pathways, advanced imaging technologies, and strong adoption of capsule endoscopy for small bowel disorders and obscure bleeding evaluation.
  • Asia Pacific is projected 10.74% CAGR driven by rising access to gastroenterology specialists, expanding healthcare infrastructure, increasing use of minimally invasive diagnostics, and broader screening across large populations.

• Segment Momentum:

  • Hospitals represented 58.3% of the market in 2025 because they offer specialist oversight, diagnostic infrastructure, and integrated care pathways that support consistent capsule endoscopy utilization.
  • Colon Capsule Endoscopy is the fastest-growing type, driven by increasing interest in less invasive colon assessment options that offer greater procedural flexibility and patient comfort.

• Market Expansion Drivers:

  • Rising gastrointestinal disorders and colorectal cancer prevalence increasing diagnostic capsule utilization.
  • Growing preference for minimally invasive gastrointestinal diagnostics replacing conventional endoscopy.
  • AI-enabled lesion detection and magnetically controlled capsules improving diagnostic accuracy.

• Industry Adoption Constraints:

• Leading Market Participants:

  Top companies in the capsule endoscopy market include Medtronic plc (Ireland), Olympus Corporation (Japan), CapsoVision, Inc. (United States), IntroMedic Co., Ltd. (South Korea), AnX Robotica Corp. (United States), JINSHAN Science & Technology (Group) Co., Ltd. (China), RF Co., Ltd. (South Korea), Shangxian Minimal Invasive Inc. (China), BioCam GmbH (Germany).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2025 Market Size: USD 629.13 Million
  • 2026 Market Size: USD 15.2 billion
  • Projected Market Size: USD 1.56 Billion by 2035
  • Growth Forecasts: 9.5% CAGR (2026-2035)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Hospitals (End-use) | Small Bowel Capsule Endoscopy (Type) | OGIB (obscure GI Tract Bleeding) (Application)
  • Emerging Opportunity Segment: Hospitals (End-use) | Colon Capsule Endoscopy (Type) | Small Intestine Tumor (Application)

Market Growth Drivers and Industry Trends

Rising gastrointestinal disorders and colorectal cancer prevalence increasing diagnostic capsule utilization

As the clinical burden of inflammatory bowel disease, obscure gastrointestinal bleeding, celiac disease, and colorectal cancer rises, providers are under greater pressure to expand diagnostic capacity beyond conventional scopes, especially for patients with suspected small-bowel pathology or cases where standard endoscopy is incomplete or poorly tolerated. That dynamic is increasing demand for the capsule endoscopy market because swallowable imaging capsules offer a practical route to earlier visualization of lesions, bleeding sources, and mucosal abnormalities without adding the infrastructure constraints associated with more invasive procedures. Screening pathways, gastroenterology referrals, and follow-up investigations increasingly convert into capsule-based assessments in patient groups where diagnostic yield and tolerability directly influence physician ordering behavior.

Growing preference for minimally invasive gastrointestinal diagnostics replacing conventional endoscopy

Patient and provider preference is shifting toward procedures that reduce discomfort, sedation requirements, recovery time, and hospital resource use, and that change is influencing market adoption in the capsule endoscopy market in a very direct way. When diagnostic decisions involve frail elderly patients, individuals reluctant to undergo conventional endoscopy, or cases where repeated monitoring is needed, capsule-based testing often becomes the more acceptable option, improving compliance and reducing deferrals. This practical advantage supports market expansion by helping hospitals and specialty clinics broaden gastrointestinal imaging access while easing procedural bottlenecks tied to endoscopy suite availability, staffing, and post-procedure observation.

AI-enabled lesion detection and magnetically controlled capsules improving diagnostic accuracy

Technology upgrades are supporting market development in the capsule endoscopy market by addressing two of the category’s most important commercial barriers: interpretation burden and diagnostic confidence. AI-assisted review tools help clinicians identify subtle bleeding, polyps, ulcers, and other abnormalities more efficiently in large image datasets, which improves workflow economics and makes capsule studies easier to integrate into routine gastroenterology practice. Magnetically controlled capsules extend that value by giving physicians more control over visualization in anatomically challenging areas, supporting more reliable examinations and increasing willingness among care providers to invest in advanced capsule platforms rather than treating them as niche adjunct tools.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising gastrointestinal disorders and colorectal cancer prevalence increasing diagnostic capsule utilization	2.00%	High	North America, Europe	High	Near Term
Growing preference for minimally invasive gastrointestinal diagnostics replacing conventional endoscopy	1.70%	High	North America, Asia Pacific	High	Mid Term
AI-enabled lesion detection and magnetically controlled capsules improving diagnostic accuracy	1.40%	High	North America, Europe, Asia Pacific	Medium	Mid Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held the leading regional position in 2025, accounting for a 46.16% share of the capsule endoscopy market. This leadership is sustained by established gastrointestinal diagnostic pathways, broad availability of advanced imaging technologies, and strong physician familiarity with minimally invasive endoscopic alternatives. In practice, healthcare providers across the region are better positioned to integrate capsule-based diagnostics into routine evaluation of small bowel disorders, obscure gastrointestinal bleeding, and related conditions, which supports consistent procedure volumes and device adoption.

Asia Pacific is projected to expand at a 10.74% CAGR over the forecast period in the capsule endoscopy market. Growth is being fueled by rising access to specialist gastroenterology services, expanding healthcare infrastructure, and increasing use of less invasive diagnostic methods in large patient populations. Across the region, adoption is accelerating as hospitals and diagnostic centers add advanced screening and imaging capabilities, allowing capsule-based procedures to reach more patients who previously had limited access to such gastrointestinal diagnostic options.

Regional Market Attractiveness & Strategic Fit Matrix
Parameter	North America	Asia Pacific	Europe	Latin America	MEA
Innovation Hub	Advanced	Developing	Advanced	Developing	Nascent
Cost-Sensitive Region	Low	Medium	Low	High	High
Regulatory Environment	Supportive	Neutral	Restrictive	Neutral	Neutral
Demand Drivers	Strong	Moderate	Strong	Moderate	Weak
Development Stage	Developed	Developing	Developed	Developing	Emerging
Adoption Rate	High	Medium	High	Medium	Low
New Entrants / Startups	Dense	Moderate	Dense	Sparse	Sparse
Macro Indicators	Strong	Stable	Stable	Weak	Weak

Key Country Insights

Germany

Diagnostic Workflow Integration

Germany emphasizes capsule endoscopy systems that integrate smoothly into gastroenterology practices and hospital diagnostic workflows. Clinical adoption in Germany is supported by demand for reliable imaging quality, efficient reporting, and streamlined patient assessment.

France

Patient-Centered Evaluation

France promotes capsule endoscopy as a practical option for gastrointestinal assessment when conventional procedures are less suitable. Healthcare providers across France prioritize patient experience, dependable image quality, and efficient clinical interpretation within routine practice.

Italy

Gastroenterology Practice Expansion

Italy continues to integrate capsule endoscopy into gastroenterology services to broaden access to minimally invasive diagnostic evaluation. Clinical facilities in Italy focus on technologies that improve workflow efficiency while supporting accurate visualization of the gastrointestinal tract.

Japan

Early Gastrointestinal Assessment

Japan prioritizes capsule endoscopy for comprehensive gastrointestinal evaluation, particularly where minimally invasive diagnostics are preferred. Healthcare providers in Japan focus on imaging accuracy, patient comfort, and technologies that complement established endoscopic services.

South Korea

Digital Imaging Advancement

South Korea supports wider adoption of capsule endoscopy through advanced imaging technologies and digitally enabled diagnostic workflows. Gastroenterology centers in South Korea increasingly value systems that improve image analysis efficiency and enhance patient convenience.

United States

Non-Invasive Diagnostics

The U.S. continues to expand the use of capsule endoscopy as clinicians seek less invasive approaches for gastrointestinal evaluation. Healthcare providers in the U.S. prioritize high-quality imaging, efficient data interpretation, and integration into established diagnostic pathways.

Segment Leadership and Growth Trends

  End-use Segment Analysis: Hospitals (Largest & Fastest-Growing Segment)

Hospitals accounted for a 58.3% share of the capsule endoscopy market in 2025, reflecting their established role as the primary care setting for gastrointestinal diagnostics that require coordinated clinical evaluation, specialist oversight, and follow-up intervention. Their leadership is maintained through the routine availability of gastroenterologists, diagnostic infrastructure, and patient referral volumes that support consistent capsule endoscopy adoption across a broad case mix. The same operational advantages are also driving continued growth, as hospitals remain the most practical environment for integrating capsule-based imaging into structured diagnostic pathways, especially where patients need comprehensive assessment and rapid escalation to additional procedures if findings warrant it.

Type Segment Analysis: Small Bowel Capsule Endoscopy (Largest Segment) vs Colon Capsule Endoscopy (Fastest-Growing Segment)

In 2025, Small Bowel Capsule Endoscopy held a 57.4% share of the capsule endoscopy market, underpinned by its established use in evaluating portions of the gastrointestinal tract that are harder to access with conventional endoscopic methods. Its strongest position is maintained by the practical clinical value it offers in routine diagnostic workflows, particularly where direct visualization of the small intestine is central to investigation and management decisions. That sustained utility keeps Small Bowel Capsule Endoscopy firmly embedded in provider practice patterns and referral pathways.

Colon Capsule Endoscopy is the fastest-growing type in the capsule endoscopy market because it is gaining traction where less invasive diagnostic approaches are increasingly valued in colon assessment. Its momentum relative to other capsule formats comes from growing interest in expanding visualization options for patients who may not be well suited to conventional procedures or where alternative examination pathways are being considered. As clinical settings look for diagnostic methods that can align with patient comfort and procedural flexibility, Colon Capsule Endoscopy is seeing stronger uptake.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
End-use	Hospitals, Outpatient Facilities	Hospitals	Hospitals
Type	Small Bowel Capsule Endoscopy, Esophageal Capsule Endoscopy, Colon Capsule Endoscopy, Others	Small Bowel Capsule Endoscopy	Colon Capsule Endoscopy
Application	OGIB (obscure GI Tract Bleeding), Crohn's Disease, Small Intestine Tumor, Others	OGIB (obscure GI Tract Bleeding)	Small Intestine Tumor

Competitive Landscape and Market Positioning

Leading companies in the capsule endoscopy market:

1. Medtronic plc (Ireland)

2. Olympus Corporation (Japan)

3. CapsoVision Inc. (United States)

4. IntroMedic Co. Ltd. (South Korea)

5. AnX Robotica Corp. (United States)

6. JINSHAN Science & Technology (Group) Co. Ltd. (China)

7. RF Co. Ltd. (South Korea)

8. Shangxian Minimal Invasive Inc. (China)

9. BioCam GmbH (Germany)

The capsule endoscopy market is evolving rapidly with advancements in high-resolution imaging, AI-assisted diagnostics, and extended battery performance aimed at improving gastrointestinal disease detection. Continuous product development focused on patient comfort, data accuracy, and non-invasive diagnostic capabilities is strengthening competitiveness and expanding adoption across healthcare facilities.

Industry Development/News

Company Name	Date	Key Development
University Hospitals Birmingham	May-26	The University Hospitals Birmingham NHS Foundation Trust has integrated capsule endoscopy into its gastrointestinal diagnostic services. This implementation of minimally invasive, non-invasive imaging technology is designed to streamline small bowel examination workflows and improve patient access to diagnostic procedures within the hospital’s clinical environment.
EgyptAir Hospital	Apr-26	EgyptAir Hospital has officially launched its capsule endoscopy program, introducing minimally invasive gastrointestinal diagnostic capabilities to its facility. This development marks the expansion of non-invasive screening options for local patients, reflecting the growing adoption of ingestible camera technology in regional healthcare systems.
CapsoVision	Nov-25	CapsoVision submitted an application to the FDA for Breakthrough Device Designation to adapt its capsule endoscopy platform for early-stage pancreatic cancer screening. This strategic initiative aims to expand the clinical utility of capsule diagnostics beyond traditional small-bowel imaging, targeting high-mortality indications where non-invasive, early detection tools are currently limited.
Helmholtz Munich	Aug-25	Helmholtz Munich, in partnership with academic collaborators, has developed a novel endoscopy imaging technique known as "O2E." This advanced technology significantly improves the visualization of early-stage tissue abnormalities, offering potential for enhanced detection of esophageal cancer and signaling technical progress in high-resolution endoscopic screening.
Magnetically Controlled Capsule Endoscopy (MCCE)	Aug-25	Magnetically Controlled Capsule Endoscopy (MCCE) technology has been deployed in Guam, providing a sedative-free, non-invasive diagnostic alternative to traditional endoscopy. This rollout significantly increases regional accessibility to gastrointestinal imaging, offering an efficient solution for patients requiring diagnostic screening without the need for invasive sedation procedures.
Public Health System Fiji	Feb-25	The Public Health System of Fiji has incorporated capsule endoscopy into its clinical diagnostic offerings. This adoption enables the provision of minimally invasive gastrointestinal assessments that support faster patient recovery and allow for the immediate resumption of normal daily activities, effectively enhancing the efficiency of the national diagnostic service.
AIG Hospitals	Dec-24	AIG Hospitals launched the PillBot robotic capsule endoscopy solution to augment or replace conventional endoscopic procedures. This integration of advanced robotic imaging represents a significant shift toward automated, non-invasive gastrointestinal diagnostic workflows, enhancing the precision and accessibility of screening services for complex digestive conditions.
Guam Regional Medical City	Nov-24	Guam Regional Medical City, in partnership with Guam Memorial Hospital, GI Digital, and USC Keck School of Medicine, launched a telemedicine-supported capsule endoscopy service. Funded by a telehealth grant, this program provides a lower-cost alternative to conventional colonoscopies, significantly improving diagnostic access for the local population through remote clinical oversight.
Odisha Health Department	Jan-24	The Odisha Health Department has deployed AI-powered endoscopy systems across its facilities to improve the diagnosis and treatment of gastrointestinal disorders. By integrating artificial intelligence into endoscopic imaging, the department aims to increase clinical accuracy and operational efficiency in identifying and managing diverse digestive tract conditions.
GIQuIC	Mar-23	The GI Quality Improvement Consortium (GIQuIC) partnered with Health Catalyst to modernize its national gastroenterology clinical registry. By utilizing Health Catalyst’s data and analytics platform, GIQuIC is streamlining registry operations for colonoscopy and EGD procedures, facilitating more robust data collection and quality reporting to drive clinical outcomes across the gastroenterology landscape.